FLORHAM PARK, N.J., June 05, 2023 PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious. | June 5, 2023
FLORHAM PARK, N.J. — FLORHAM PARK, N.J. — PDS Biotechnology Corporation on Monday reported a loss of $9.7 million in its first quarter. On a per-share basis, the Florham Park, New. | May 15, 2023
Item 8.01 Other Events.
On April 6, 2023, PDS Biotechnology Corporation updated its corporate
presentation deck. A copy of the corporate presentation is filed as Exhibit 99.1
and incorporated herein. | April 6, 2023
FLORHAM PARK, N.J., April 03, 2023 PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious. | April 3, 2023
FLORHAM PARK, N.J., March 29, 2023 PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious. | March 29, 2023